![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | Universal Diagnostics Universal Diagnostics (UDX) is a bioinformatics, multi-omics, and in-vitro diagnostics company that develops minimally invasive and blood-based solutions for detecting cancer. | ||
Founding Date | Founding Date 1993 | Founding Date 2012 | Founding Date 2001 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Seville, ES HQ Ljubljana, SI Madrid, ES Cambridge, US | Locations Dunedin, NZ HQ Singapore, SG |
Employees | Employees 878% decrease | Employees 1271% increase | Employees 114 |
Financial | |||
Revenue (est.) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $11.5m (FY, 2026) |
Cost of goods | Cost of goods $28.4m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ($2.5m) (FY, 2022) | Gross profit N/A | Gross profit $13m (FY, 2026) |
Net income | Net income ($32.1m) (FY, 2022) | Net income N/A | Net income ($35.8m) (FY, 2026) |
Universal Diagnostics (UDX) is a bioinformatics, multi-omics, and in-vitro diagnostics company that develops minimally invasive and blood-based solutions for detecting cancer.
View company